ESPERANCE PHARMACEUTICALS, INC

Profile

Company Names

ESPERANCE PHARMACEUTICALS, INC

Addresses

TWO HOUSTON CENTER, 909 FANNIN, SUITE 2000, HOUSTON, TX 77010

LOUISIANA EMERGING TECHNOLOGY CENTER, 340 EAST PARKER BLVD, BATON ROUGE, LA 70803

Phone Numbers

713-276-7600
225-615-8952

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$19,433,871.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-06-28 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
3
2011-05-27 
$5,733,626.00 
$7,500,000.00 
$1,766,374.00 
Equity 
2
2008-11-13 
$3,700,245.00 
$5,750,001.00 
$2,049,756.00 
Equity 
1
2006-10-18 
$9,000,000.00 
$9,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HECTOR 
 
ALILA 
EXECUTIVE OFFICER, DIRECTOR
ESPERANCE PHARMACEUTICALS, INC
RICHARD 
 
BABB 
EXECUTIVE OFFICER
ESPERANCE PHARMACEUTICALS, INC   |  SERVATO CORP.   |  OMNIDEK INC.   |  CURA OS, INC.   |  CALOSYN PHARMA, INC.
ROSS 
 
BARRETT 
DIRECTOR
CALOSYN PHARMA, INC.   |  ESPERANCE PHARMACEUTICALS, INC   |  EMBERA NEUROTHERAPEUTICS, INC.   |  NUME HEALTH, LLC   |  NUPOTENTIAL, INC.   |  MICROBIOME THERAPEUTICS, LLC   |  A28 THERAPEUTICS, INC.   |  CANCER FOCUS FUND II, LP
SONIA 
 
DEGGS 
EXECUTIVE OFFICER
ESPERANCE PHARMACEUTICALS, INC
PETER 
 
HOANG 
DIRECTOR
TAPIMMUNE INC.   |  ESPERANCE PHARMACEUTICALS, INC   |  MONGOOSE BIO, INC.
CAROLA 
 
LEUSCHNER 
EXECUTIVE OFFICER
ESPERANCE PHARMACEUTICALS, INC
JOSEPH 
 
LOVETT 
DIRECTOR
ESPERANCE PHARMACEUTICALS, INC   |  EMBERA NEUROTHERAPEUTICS, INC.   |  CALOSYN PHARMA, INC.   |  DOWLEY SECURITY SYSTEMS, INC.   |  BIOCEPTIVE, INC.
CHAD 
 
SOUVIGNIER 
DIRECTOR
ESPERANCE PHARMACEUTICALS, INC   |  OPTOFLUIDICS, INC.   |  BIOLOG, INC. /DE/   |  SEQWELL INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-06-28 
2011-06-09
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-05-27 
2010-05-03
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2006-10-18 
2010-05-03
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2008-11-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#